
Enzymaster raises $45m in Series C round
The Series C financing round was led by Yuanbio Venture Capital with While Bayland Capital, Puhua Capital, C&D Emerging Capital, Hansoh...

Gilde Healthcare Private Equity IV launches €517m
The new oversubscribed fund will focus its investements on firms with an active buy-and-build strategy and is designed to invest in all sub-segments...

Bavarian Nordic bags $225m for licence to RSV vaccine
Under the terms of the agreement, Bavarian Nordic A/S (Copenhagen) will receive an upfront payment of US$12.5m and potential milestone payments of up...

Meletios Therapeutics licences antiviral patent
Meletios has signed an exclusive license agreement with Institut Pasteur to commercialise Defective Viral Genomes (DVG). DVGs are truncated or...

ECBF oversubscribed closing at €300m
According to the industry experts, the biologisation of industrial production by means of sustainable bacterial-enzymatic or cell-culture-based...

Sanofi bags €300m from US investor Blackstone
French Sanofi has secured €300m from US equity financing specialist Blackstone Life Sciences to accelerate pivotal studies of its subcutanous...

Engimmune Therapeutics raises CHF15.5m in seed financing
Pureos Bioventures and Novo Holdings co-led the financing of Engimmune Therapeutics, a spin-off from the research group of Prof. Sai Reddy at the...